396 related articles for article (PubMed ID: 7514109)
21. Role of nitric oxide formation in the regulation of haemodynamics and the release of noradrenaline and adrenaline.
Halbrügge T; Lütsch K; Thyen A; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):720-7. PubMed ID: 1775203
[TBL] [Abstract][Full Text] [Related]
22. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo.
Persson MG; Gustafsson LE; Wiklund NP; Moncada S; Hedqvist P
Acta Physiol Scand; 1990 Dec; 140(4):449-57. PubMed ID: 1707210
[TBL] [Abstract][Full Text] [Related]
23. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
24. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure.
Cooper CJ; Jevnikar FW; Walsh T; Dickinson J; Mouhaffel A; Selwyn AP
Am J Cardiol; 1998 Sep; 82(5):609-14. PubMed ID: 9732889
[TBL] [Abstract][Full Text] [Related]
25. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats.
Izuta M; Clavier N; Kirsch JR; Traystman RJ
Stroke; 1995 Jun; 26(6):1079-85. PubMed ID: 7539167
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans.
Owlya R; Vollenweider L; Trueb L; Sartori C; Lepori M; Nicod P; Scherrer U
Circulation; 1997 Dec; 96(11):3897-903. PubMed ID: 9403613
[TBL] [Abstract][Full Text] [Related]
27. Endothelium-dependent circulatory control--a mechanism for the differing peripheral vascular effects of isoflurane versus halothane.
Greenblatt EP; Loeb AL; Longnecker DE
Anesthesiology; 1992 Dec; 77(6):1178-85. PubMed ID: 1466468
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries.
Crawley DE; Liu SF; Evans TW; Barnes PJ
Br J Pharmacol; 1990 Sep; 101(1):166-70. PubMed ID: 2282458
[TBL] [Abstract][Full Text] [Related]
30. Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humans.
Blitzer ML; Lee SD; Creager MA
Am J Physiol; 1996 Sep; 271(3 Pt 2):H1182-5. PubMed ID: 8853358
[TBL] [Abstract][Full Text] [Related]
31. Relative contribution of endothelium-derived relaxation factor to vascular tone in the systemic, pulmonary, and cerebral circulations of piglets.
Rudinsky B; Bell A; Hipps R; Meadow W
Dev Pharmacol Ther; 1993; 20(3-4):152-61. PubMed ID: 7828447
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide inhibition attenuates systemic hypotension produced by protamine.
Raikar GV; Hisamochi K; Raikar BL; Schaff HV
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1240-6; discussion 1246-7. PubMed ID: 8642826
[TBL] [Abstract][Full Text] [Related]
33. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
34. Postsynaptic α1-Adrenergic Vasoconstriction Is Impaired in Young Patients With Vasovagal Syncope and Is Corrected by Nitric Oxide Synthase Inhibition.
Stewart JM; Suggs M; Merchant S; Sutton R; Terilli C; Visintainer P; Medow MS
Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27444639
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats.
Loeb AL; Longnecker DE
Am J Physiol; 1992 May; 262(5 Pt 2):H1494-500. PubMed ID: 1590453
[TBL] [Abstract][Full Text] [Related]
36. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans.
Joannides R; Richard V; Haefeli WE; Linder L; Lüscher TF; Thuillez C
Hypertension; 1995 Aug; 26(2):327-31. PubMed ID: 7635543
[TBL] [Abstract][Full Text] [Related]
37. Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans.
Ide K; Worthley M; Anderson T; Poulin MJ
J Physiol; 2007 Oct; 584(Pt 1):321-32. PubMed ID: 17673507
[TBL] [Abstract][Full Text] [Related]
38. Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock.
Zhang H; Rogiers P; Smail N; Cabral A; Preiser JC; Peny MO; Vincent JL
J Appl Physiol (1985); 1997 Oct; 83(4):1164-73. PubMed ID: 9338425
[TBL] [Abstract][Full Text] [Related]
39. Effect of nitric oxide synthase inhibition on bleeding time in humans.
Simon DI; Stamler JS; Loh E; Loscalzo J; Francis SA; Creager MA
J Cardiovasc Pharmacol; 1995 Aug; 26(2):339-42. PubMed ID: 7475061
[TBL] [Abstract][Full Text] [Related]
40. Effect of systemic nitric oxide synthase inhibition on postexercise hypotension in humans.
Halliwill JR; Minson CT; Joyner MJ
J Appl Physiol (1985); 2000 Nov; 89(5):1830-6. PubMed ID: 11053333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
